If Cheng Gang hadn't completely lost power in the internal power struggle, Zhang Weimin wouldn't have thought of leaving.
The main challenges at Kechuang Biotechnology come from strategic aspects.
With Zheng Li overseeing the entire technical field, Zhang Weimin has neither the need nor the space to interfere.
His work mainly involves considering the application areas of brain-computer interfaces and how to collaborate with other companies to expand influence.
Backed by cutting-edge brain-computer interface technology, the requirements and challenges of this job are not particularly high.
Therefore, with his boss changing, Zhang Weimin felt a great sense of crisis, as no one knew whether they would be laid off.
The opportunity presented itself to him by Neuralink. It was only natural for him to go from America to China and then decide to return to America.
Even though he had become the general manager of Neuralink and Neuralink had a new major shareholder—FB, Zhang Weimin was still not optimistic about Neuralink's future.
Facebook has been declining in recent years, but it remains a synonym for deep pockets and wealth.
Research and investment are somewhat correlated, but this does not mean that companies with high investment will necessarily achieve good results.
Back then, IBM's R&D investment in the personal computer field far exceeded that of companies like Microsoft, Dell, and Compaq, but it was not IBM that shone brightly in the personal PC era.
After Steve Jobs returned to Apple, he drastically cut the company's R&D spending, and Apple successfully revived itself with far less R&D investment than before.
As a senior manager with considerable experience in both industry and academia and a unique understanding of scientific research, Zhang Weimin does not believe that introducing new shareholders or more funding will be of much help to Neuralink.
In the development of technology, luck is sometimes more important than investment.
Musk's hints were a key factor in his ability to impress Zhang Weimin.
Musk stated that if they can develop brain-computer interface technology that is close to that of Crescent, the American government will not hesitate to reject Crescent's products.
As for now? No.
Kechuang Bio's brain-computer interface VR and brain-computer interface prosthetics are gaining popularity in the American market.
Brain-computer interface VR is considered an entertainment product, so banning it won't cause major problems.
However, banning brain-computer interface VR would directly affect votes.
After shaking hands with Musk, Zhang Weimin said, "I believe we will succeed."
"But the primary goal now is to achieve a recognition accuracy of 95% for brain-computer interfaces."
"In this way, our brain-computer interface technology can be applied to more high-end models."
"Including entering the Chinese market."
"Then comes brain-computer interface VR."
"It's fine to let Kechuang Bio's brain-computer interface VR be implemented a few years ahead of schedule. We can learn from their solutions when the time comes."
From a certain perspective, Zhang Weimin is also optimistic. Because he feels that catching up with the science and technology innovation industry is almost impossible.
However, by leveraging administrative blockades and possessing the entire America market, Neuralink could become a company with a market capitalization exceeding 100 billion US dollars.
If handled well, it could even lead to a blockade of Kechuang Bio's products in the European market.
Of course, it would be very difficult to get Europe and America to unite in a blockade against a single company.
However, Musk is quite confident that the blockade of scientific and technological innovation products will only be imposed on some countries in Europe.
Although some countries in the European continent are nominally members of the Europa Union, America's influence over them far exceeds that of the Europa Union.
......
After the pandemic ended, Li Miaomiao went to Singapore about once a month.
Singapore is starting to get hot in April, and the tropical rainforest climate means that most people on the streets of Singapore are wearing short sleeves during this season.
Li Miaomiao was wearing a professional short skirt, which was somewhat out of place with the overall dress code of the Lion City R&D Center.
Under Zheng Li's leadership, the researchers here basically do whatever makes them comfortable.
Aside from wearing a white lab coat when conducting experiments, most people in public office areas wear short sleeves and shorts.
Zheng Li was wearing a dark blue short-sleeved shirt with a floral pattern: "Has Cheng Gang been handing over his work to you during this period?"
Li Miaomiao nodded and said, "Cheng Gang has handed over most of the work to me. The personnel, finance, and business information have been initially transferred to me."
"Zhang Weimin also left; he went to Neuralink to become the general manager."
Zheng Li nodded: "I know Zhang is a good talent, but the price Neuralink offered is beyond our reach."
Li Miaomiao: "He's gone, so he's gone. His departure doesn't have much impact on us."
"I just didn't expect Neuralink to choose Zhang Weimin even though they were willing to pay the penalty for breach of contract."
"Even with Zhang joining Neuralink, they cannot pose any effective threat to us."
"And I heard that Neuralink tried to poach Cheng Gang before they poached Zhang, but Cheng Gang declined their offer."
"Musk is being a bit too obsessed with poaching executives from tech companies."
Successful companies are able to add value to their employees.
Ahri's eighteen Arhats are just like that.
Gu Mao
The same logic applies to the executives at Kechuang Biotechnology.
Cheng Gang was originally just an unknown investor, far inferior to big names like Zhang Lei and Shen Nanpeng, and even to Young.
This chapter is not finished, please click the next page to continue reading!
Continue read on readnovelmtl.com